Showing 1 - 3 results of 3 for search 'S. Marjasuo', query time: 0.02s Refine Results
  1. 1
    Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.

    Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy. by Kevin Sandeman, Juho T Eineluoto, Joona Pohjonen, Andrew Erickson, Tuomas P Kilpeläinen, Petrus Järvinen, Henrikki Santti, Anssi Petas, Mika Matikainen, Suvi Marjasuo, Anu Kenttämies, Tuomas Mirtti, Antti Rannikko

    Published 2020-01-01
    Get full text
    Article
  2. 2
    Expected impact of MRI related interreader variability on ProScreen prostate cancer screening trial

    Expected impact of MRI related interreader variability on ProScreen prostate cancer screening trial by R. Hietikko, T.P. Kilpeläinen, A. Kenttämies, J. Ronkainen, K. Ijäs, K. Lind, S. Marjasuo, J. Oksala, O. Oksanen, T. Saarinen, R. Savolainen, K. Taari, T.L.J. Tammela, T. Mirtti, K. Natunen, A. Auvinen, A. Rannikko

    Published 2020-07-01
    Get full text
    Article
  3. 3
    Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study

    Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study by Ronja Hietikko, Tuomas P. Kilpeläinen, Anu Kenttämies, Johanna Ronkainen, Kirsty Ijäs, Kati Lind, Suvi Marjasuo, Juha Oksala, Outi Oksanen, Tuomas Saarinen, Ritja Savolainen, Kimmo Taari, Teuvo L. J. Tammela, Tuomas Mirtti, Kari Natunen, Anssi Auvinen, Antti Rannikko

    Published 2020-10-01
    Get full text
    Article

Search Tools: